MR-ProADM Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Biomarker assessment

Enter the measured mid-regional pro-adrenomedullin (MR-proADM) concentration.

MR-proADM nmol/L

Use a numeric laboratory result greater than or equal to zero. Enter decimals with a period (for example, 0.87).

About MR-proADM

Mid-regional pro-adrenomedullin (MR-proADM) is a stable fragment of the adrenomedullin precursor. Concentrations may reflect endothelial dysfunction and severity of illness, and have been investigated for risk assessment in patients with suspected infection and sepsis.

Published studies use different thresholds depending on the population and outcome. The values shown here are evidence-informed reference bands, not universally validated categories of mortality risk.

Reference thresholds used in this tool

ConcentrationEvidence contextHow to interpret
<0.87 nmol/L Studied as a lower-risk threshold in suspected-infection emergency-department cohorts. May support—but cannot independently determine—lower-risk triage.
0.87 to <1.54 nmol/L Between two thresholds reported in progression-risk research. No universal risk percentage is assigned to this interval.
≥1.54 nmol/L Associated with increased disease progression risk in a multicentre derivation/validation study. Consider with clinical findings and validated severity tools.

Important limitations

  • MR-proADM is an adjunct and must not replace clinical assessment or established sepsis pathways.
  • Do not infer a fixed mortality percentage or ICU requirement from these bands alone.
  • Thresholds may not transfer directly across assay platforms, populations, or clinical settings.
  • Urgent signs of deterioration require immediate clinical evaluation regardless of the biomarker value.

References

Schuetz P, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Critical Care. 2019. The study evaluated MR-proADM thresholds including <0.87 and ≥1.54 nmol/L in suspected infection. doi:10.1186/s13054-019-2329-5
Li P, Wang C, Pang S. The diagnostic accuracy of mid-regional pro-adrenomedullin for sepsis: a systematic review and meta-analysis. Minerva Anestesiologica. 2021;87(10):1117–1127. The meta-analysis reported variable diagnostic thresholds, with a best diagnostic cut-off around 1–1.5 nmol/L. doi:10.23736/S0375-9393.21.15585-3 · PubMed PMID: 34134460
Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. This study of patients with severe sepsis/septic shock reported prognostic performance and a 0.88 nmol/L threshold in a specific ICU cohort; it should not be generalized as a universal discharge threshold. PubMed PMID: 28185230
Clinical disclaimer: This tool provides an educational interpretation of a biomarker result. It is not a diagnostic test, validated stand-alone risk score, or substitute for professional clinical judgement, local protocols, or urgent assessment when clinically indicated.